Revvity Stock Today

RVTY Stock   116.23  1.16  1.01%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 3

 
High
 
Low
Very Low
Revvity is trading at 116.23 as of the 28th of November 2024; that is 1.01% up since the beginning of the trading day. The stock's open price was 115.07. Revvity has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Revvity are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
6th of April 1983
Category
Healthcare
Classification
Health Care
Revvity is entity of United States. It is traded as Stock on NYSE exchange. The company has 121.7 M outstanding shares of which 4.09 M shares are at this time shorted by private and institutional investors with about 4.16 trading days to cover. More on Revvity

Moving together with Revvity Stock

  0.82A Agilent TechnologiesPairCorr

Moving against Revvity Stock

  0.55ESPR Esperion TherapeuticsPairCorr
  0.46BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.38DRUG Bright Minds BiosciencesPairCorr

Revvity Stock Highlights

ESG Sustainability
Environmental
Governance
Social
President CEOPrahlad Singh
Business ConcentrationLife Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, SP 500 Index, Health Care, Life Sciences Tools & Services, Diagnostics & Research, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.06040.0511
Fairly Up
Very volatile
Asset Turnover0.190.2028
Notably Down
Slightly volatile
Gross Profit Margin0.30.5598
Way Down
Slightly volatile
Net Debt3.3 B3.2 B
Sufficiently Up
Slightly volatile
Total Current Liabilities1.5 B1.5 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total4.5 B4.2 B
Sufficiently Up
Slightly volatile
Total Assets14.2 B13.6 B
Sufficiently Up
Slightly volatile
Total Current Assets3.2 BB
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities86.7 M91.3 M
Notably Down
Slightly volatile
Debt Levels
Revvity can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Revvity's financial leverage. It provides some insight into what part of Revvity's total assets is financed by creditors.
Liquidity
Revvity currently holds 4.07 B in liabilities. Note, when we think about Revvity's use of debt, we should always consider it together with its cash and equity.

Capital Expenditures

50.41 Million
Revvity (RVTY) is traded on New York Stock Exchange in USA. It is located in 940 Winter Street, Waltham, MA, United States, 02451 and employs 11,000 people. Revvity is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 14 B. Revvity conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 121.7 M outstanding shares of which 4.09 M shares are at this time shorted by private and institutional investors with about 4.16 trading days to cover. Revvity generates positive cash flow from operations, but has no cash available
Check Revvity Probability Of Bankruptcy
Ownership Allocation
Revvity owns a total of 121.7 Million outstanding shares. The majority of Revvity outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Revvity to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Revvity. Please pay attention to any change in the institutional holdings of Revvity as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Revvity Ownership Details

Revvity Historical Income Statement

At this time, Revvity's Depreciation And Amortization is fairly stable compared to the past year. EBITDA is likely to rise to about 853.9 M in 2024, whereas Interest Expense is likely to drop slightly above 57.8 M in 2024. View More Fundamentals

Revvity Stock Against Markets

Revvity Corporate Management

Andrew OkunChief VPProfile
Joel GoldbergGeneral AdministrationProfile
Jayashree ThackerSenior OfficerProfile
Madhuri FACMGSenior OfficerProfile
Bryan KippSenior LicensingProfile
Miriame VictorSenior OfficerProfile
Magali FourSenior OfficerProfile

Additional Tools for Revvity Stock Analysis

When running Revvity's price analysis, check to measure Revvity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revvity is operating at the current time. Most of Revvity's value examination focuses on studying past and present price action to predict the probability of Revvity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revvity's price. Additionally, you may evaluate how the addition of Revvity to your portfolios can decrease your overall portfolio volatility.